Even though the trial is open label, if it is being conducted correctly, there should be no analysis of the results until it is completed. Also, nobody but the investigators should be informed of the data as the trial progresses...and there should be no leaks. If any data leak, it would be bad for the clinical center's reputation, thereby risking future contracts. So I would not attach any significance to the lack of news. It means nothing.